test44
https://www.cytel.com/blog/anna-forsythe-on-aligning-clinical-strategy-with-regulatory-and-market-objectives
December 7, 2021
Sponsors bringing a successful new product to market have to overcome two hurdles: submission and reimbursement. For..
Read article
test44
https://www.cytel.com/blog/how-to-harness-technology-to-align-regulatory-and-market-access-evidence-strategies-a-new-podcast
November 17, 2021
Traditionally, the teams responsible for clinical development and regulatory submissions do not consult the market..
Read article
test44
https://www.cytel.com/blog/evolving-the-study-design-process-webcast-by-yannis-jemiai
November 10, 2021
There are many reasons why traditional approaches to designing a clinical study are generally suboptimal and do not..
Read article
test44
https://www.cytel.com/blog/empowering-trial-selection-webcast-yannis-jemiai
November 2, 2021
A good clinical study design performs well not only under the ideal target scenario. Statisticians should be able to..
Read article
test44
https://www.cytel.com/blog/leveraging-staged-investment-strategy-for-funding-novel-therapies
October 27, 2021
A staged investment strategy aligns R&D decisions and financial planning with the interim looks of a clinical trial. If..
Read article
test44
https://www.cytel.com/blog/strategic-clinical-trial-design-unlocks-innovative-financing-opportunity
October 20, 2021
For health innovators, trial selection is a key success factor as there are no second chances. But how do you find the..
Read article
test44
https://www.cytel.com/blog/weighting-and-prioritization-for-trial-selection-new-webinar
October 14, 2021
When choosing the optimal clinical trial design for a given study, sponsors face critical questions like choice of..
Read article
test44
https://www.cytel.com/blog/the-rapidly-evolving-need-for-master-protocols
October 6, 2021
Master Protocols are advanced and innovative clinical trial designs that can evaluate multiple therapies and disease..
Read article
test44
https://www.cytel.com/blog/kyle-wathen-talks-to-outsourcing-pharma-on-the-need-for-statistical-innovation
October 1, 2021
The COVID-19 pandemic elevated the challenge of designing and executing clinical trials within a substantially..
Read article
